Sara Nagy
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Safety and Efficacy of Tamoxifen in Patients with Duchenne muscular dystrophy: open Label Extension of TAMDMD Trial.
Journal: Neuromuscular disorders : NMD
Published: October 15, 2025
Automated analysis of quantitative muscle MRI and its reliability in patients with Duchenne muscular dystrophy.
Journal: Journal of neuromuscular diseases
Published: March 25, 2025
Safety and efficacy of tamoxifen in non-ambulant patients with Duchenne muscular dystrophy: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial (TAMDMD Group B).
Journal: Neuromuscular disorders : NMD
Published: September 16, 2024
Analysis of C9orf72 repeat expansions in Georgian patients with Amyotrophic lateral sclerosis (ALS).
Analysis of C9orf72 repeat expansions in Georgian patients with Amyotrophic lateral sclerosis (ALS).
Journal: F1000Research
Published: February 26, 2024
Pathologic RFC1 repeat expansions do not contribute to the development of inflammatory neuropathies.
Pathologic RFC1 repeat expansions do not contribute to the development of inflammatory neuropathies.
Journal: Brain communications
Published: October 24, 2023
RTN2 deficiency results in an autosomal recessive distal motor neuropathy with lower limb spasticity.
Journal: Brain : a journal of neurology
Published: August 30, 2023
Safety and efficacy of tamoxifen in boys with Duchenne muscular dystrophy (TAMDMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Journal: The Lancet. Neurology
Published: March 16, 2023
Intronic FGF14 GAA repeat expansions are a common cause of ataxia syndromes with neuropathy and bilateral vestibulopathy.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: March 15, 2023
Metabolic markers of short and long-term exogenous DL-beta-hydroxybutyrate supplementation in episodic migraine patients: an exploratory analysis of a randomized-controlled-trial.
Journal: Frontiers in pharmacology
Published: February 27, 2023
Deep Intronic FGF14 GAA Repeat Expansion in Late-Onset Cerebellar Ataxia.
Journal: The New England journal of medicine
Published: December 14, 2022
Inclusion body myositis: from genetics to clinical trials.
Journal: Journal of neurology
Published: October 17, 2022
Last Updated: 09/26/2026